Unknown statusInterventionalNot ApplicableUpdated Feb 26, 2019
The Feasibility of Different Doses of Etomidate Admixed With Propofol in Induced Abortion: A Randomized, Double Blind Controlled Trial | NCT02208596 | Trialant
Unknown statusInterventionalPhase 4Updated Aug 5, 2014
The Feasibility of Different Doses of Etomidate Admixed With Propofol in Induced Abortion: A Randomized, Double Blind Controlled Trial
ClinicalTrials.gov ID
NCT02208596
Lead Sponsor
Third Affiliated Hospital of Zhengzhou UniversityOTHER
Overall Status
Unknown status
Study Type
Interventional
Phase
Phase 4
Enrollment
150Estimated
Last Update Posted
Aug 5, 2014Estimated
Start Date
Sep 2014
Primary Completion Date
Feb 2015Estimated
Completion Date
Feb 2015Estimated
Brief Summary
To explore the feasibility of different doses of etomidate admixed with propofol in induced abortion: a randomized, double blind controlled trial.
Induced Abortion
Anesthesia
pentazocine
propofol
Etomidate
Ages Eligible for Study
Adult (18-64)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Aged between 20 and 35 years
American Society of Anesthesiology (ASA) Physical Status: Ⅰ or Ⅱ
Singleton pregnancy and the gestational period is 6 to 8 weeks
Expected operation duration is within 60 minutes
The body weight should be within 15% around the standard weight